GLF
AMRX icon

Groupe la Francaise’s Amneal Pharmaceuticals AMRX Stock Holding History

Groupe la Francaise’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-150
Closed -$1.26K – 474
2025
Q3 		$1.26K Buy
+150
New +$1.35K ﹤0.01% 732

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Groupe la Francaise's AMRX Position: Q4 2025 in Review

Groupe la Francaise sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 150 shares — an estimated $1.26K sold.

Groupe la Francaise first reported a position in AMRX in Q3 2025 and held it in 1 quarter. The position peaked at $1.26K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Groupe la Francaise reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Groupe la Francaise sold 150 Amneal Pharmaceuticals shares in Q4 2025, an estimated $1.26K.
  • Groupe la Francaise first reported a position in Amneal Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Groupe la Francaise's Amneal Pharmaceuticals position peaked at $1.26K in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Groupe la Francaise's 13F filing for Q4 2025, filed 12 Feb 2026.